Home
/
Traws Pharma, Inc. (TRAW)
Traws Pharma, Inc. (TRAW) Technical Analysis
Updated: 2026-03-17 00:40 UTC · Last close: 2.11 (+5.50%)
Traws Pharma, Inc. (TRAW) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
The latest close for Traws Pharma, Inc. (TRAW) came in at 2.11 (+5.50%). Price continues to hold above both the 50-day and 200-day moving averages, which keeps the broader trend structure constructive. 20-day momentum is notably strong at +9.90%, with price remains inside its roughly 52-week range (1.09–3.13), while ATR14 volatility is elevated at roughly 9.99% of price. RSI(14) is 62.9, which keeps short-term momentum constructive without being overly stretched. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram is positive and expanding, pointing to improving upside momentum. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. Near-term structure is defined by support at 1.85 and resistance at 2.40. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Revenue: 2.79M · Net income: 16.61M · EPS (basic): 1.56. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.
Fundamentals Snapshot
Source: sec
Company
Traws Pharma, Inc.
Note: This is an algorithmic technical snapshot (not financial advice).